StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) stock

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3085% above fair value
$270.47+3.33 (+1.25%)

Close on Nov 20, 2026Market cap $651.11BP/E 41.0Yield 1.90%

Johnson & Johnson shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Johnson & Johnson's shares outstanding was 2.45B at Sep 27, 2026. For fiscal 2025 it was 2.43B, up 0.0% from the year before. Over ten years it grew -1.5% a year on average. The highest annual figure on record is 2.91B in fiscal 2007.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 28, 20252.43B0.0%
FY2024Dec 29, 20242.43B-5.1%
FY2023Dec 31, 20232.56B-3.9%
FY2022Jan 1, 20232.66B-0.4%
FY2021Jan 2, 20222.67B+0.1%
FY2020Jan 3, 20212.67B-0.5%
FY2019Dec 29, 20192.68B-1.6%
FY2018Dec 30, 20182.73B-0.6%
FY2017Dec 31, 20172.75B-1.6%
FY2016Jan 1, 20172.79B-0.9%
FY2015Jan 3, 20162.81B-1.8%
FY2014Dec 28, 20142.86B-0.5%
FY2013Dec 29, 20132.88B+2.3%
FY2012Dec 30, 20122.81B+1.3%
FY2011Jan 1, 20122.78B-0.5%
FY2010Jan 2, 20112.79B-0.0%
FY2009Jan 3, 20102.79B-1.6%
FY2008Dec 28, 20082.84B-2.6%
FY2007Dec 30, 20072.91B–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 20262.45B+0.8%
Q2 FY2026Jun 28, 20262.44B+0.9%
Q1 FY2026Mar 29, 20262.45B+0.9%
Q4 FY2025Dec 28, 20252.44B+0.6%
Q3 FY2025Sep 28, 20252.43B+0.0%
Q2 FY2025Jun 29, 20252.42B-0.1%
Q1 FY2025Mar 30, 20252.42B-0.3%
Q4 FY2024Dec 29, 20242.43B-0.1%
Q3 FY2024Sep 29, 20242.43B-4.8%
Q2 FY2024Jun 30, 20242.42B-7.8%
Q1 FY2024Mar 31, 20242.43B-6.7%
Q4 FY2023Dec 31, 20232.43B-8.4%
Q3 FY2023Oct 1, 20232.55B-4.2%
Q2 FY2023Jul 2, 20232.63B-1.6%
Q1 FY2023Apr 2, 20232.61B-2.3%
Q4 FY2022Jan 1, 20232.65B-0.7%
Q3 FY2022Oct 2, 20222.66B-0.5%
Q2 FY2022Jul 3, 20222.67B-0.1%
Q1 FY2022Apr 3, 20222.67B-0.2%
Q4 FY2021Jan 2, 20222.67B+0.1%
Q3 FY2021Oct 3, 20212.67B+0.2%
Q2 FY2021Jul 4, 20212.67B+0.2%
Q1 FY2021Apr 4, 20212.67B+0.1%
Q4 FY2020Jan 3, 20212.67B-0.1%
Q3 FY2020Sep 27, 20202.67B-0.0%
Q2 FY2020Jun 28, 20202.67B-1.0%
Q1 FY2020Mar 29, 20202.67B-1.0%
Q4 FY2019Dec 29, 20192.67B-1.9%
Q3 FY2019Sep 29, 20192.67B-2.1%
Q2 FY2019Jun 30, 20192.69B-1.1%
Q1 FY2019Mar 31, 20192.70B-1.2%
Q4 FY2018Dec 30, 20182.73B-0.6%
Q3 FY2018Sep 30, 20182.73B-0.4%
Q2 FY2018Jul 1, 20182.72B-0.7%
Q1 FY2018Apr 1, 20182.73B-0.8%
Q4 FY2017Dec 31, 20172.74B-0.9%
Q3 FY2017Oct 1, 20172.74B–
Q2 FY2017Jul 2, 20172.74B–
Q1 FY2017Apr 2, 20172.75B–
Q4 FY2016Jan 1, 20172.77B–

More Johnson & Johnson figures

See a number that looks wrong?